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                               INTRODUCTION 
Abnormal uterine bleeding is aberrant menstruation characterised by changes in 
cycle length or duration of flow or both.AUB accounts for 10% of the gynaecology 
related  complaints  1.  Thyroid  dysfunction  is  marked  by  large  number  of  menstrual 
aberrations.
Both hypothyroidism as well as hyperthyroidism is associated with a variety of 
changes in reproductive function including delayed onset of puberty, anovulatory cycles 
and abnormally high foetal wastage 2.
Clinical  experiences  show  increased  menstrual  flow  to  be  the  most  common 
reproductive  system  manifestation  of  hypothyroidism.  Although  the  occurrence  of 
menstrual  disturbances  in  hypothyroid woman has  been documented,  the  number  of 
hypothyroid  patients  originally  requiring  treatment  for  menorrhagia  has  not  been 
carefully elucidated. Moreover majority of the cases has subclinical hypothyroidism and 
easily  pass  unrecognized  and  is  now  increasingly  recognised  as  a  risk  factor  for 
menstrual problems, cardiovascular diseases and abnormal mental development in foetus 
3 .Danese MD et al recommend hypothyroidism is 
frequent enough to warrant consideration in women with menstrual dysfunction 4.
Hence this study is to evaluate the thyroid function in patients having abnormal 
menstrual bleeding in reproductive age groups which will be justifiable and will help in 
further management of AUB.
A brief outline of the physiology of menstruation and thyroid function is essential 
for the better understanding of the causal relation.
MENSTRUAL CYCLE PHYSIOLOGY
The normal menstrual cycle represents a complex interrelationship of hormones 
and physiological events in the hypothalamus, the pituitary, the ovary, and the uterus 
that  prepares  the  body  for  the  possibility  of  conception.  An  understanding of  these 
relationships is essential for evaluation of menstrual irregularities.
  NORMAL MENSTRUAL CYCLE 
 Defined as having a mean interval of 21-35 days, with duration of 2 -7 
days, menstrual flow of approximately 30ml per cycle, with an upper 
limit of normal at 60-80 ml.
 For normal cycles to occur, the following conditions must be present,
 Intact Hypothalamic –pituitary system
 Normal ovary with normal follicular components 
 Normal endometrium ,capable of responding to ovarian steroids
 Intact thyroid and adrenal functions.
Thyroid and adrenal functions has to be intact, because their aberrations exert a 
deleterious effect on the hypothalamic –pituitary-gonadotrophin system.
SEGMENTS:
The normal human menstrual cycle can be divided into two segments.
 The ovarian cycle 
 The uterine cycle 
The ovarian cycle consists of Follicular phase and Luteal phase. The uterine cycle is 
divided into Proliferative phase and Secretory phase 5.
FOLLICULAR PHASE:
This  phase  begins  with  sloughing  of  endometrium  in  day  one  of  cycle  and 
culminates  with  ovulation.  It  lasts  for  approximately  14  days  .Estrogen  is  the 
predominant  hormone  of  the  follicular  phase.  Hormonal  feedback  promotes  orderly 
development  of a single  dominant  follicle,  which should be mature at  midcycle and 
prepared for ovulation.
LUTEAL PHASE:
 The luteal phase is also called the secretory phase. An important role is played by 
the corpus luteum, the solid body formed in an ovary after the egg has been released 
from the ovary into the fallopian tube. This body continues to grow for some time after 
ovulation and produces significant amounts of hormones, particularly progesterone. 
Progesterone  plays  a  vital  role  in  making  the  endometrium  receptive  to 
implantation of the blastocyst and supportive of the early pregnancy; it also has 
the side effect of raising the basal body temperature.
After ovulation, the pituitary hormones FSH and LH cause the remaining parts of 
the dominant follicle to transform into the corpus luteum, which produces progesterone 
and estrogens. The hormones produced by the corpus luteum also suppress production of 
the FSH and LH that the corpus luteum needs to maintain itself. Consequently, the level 
of FSH and LH fall quickly over time, and the corpus luteum subsequently atrophies. 
Falling levels of progesterone trigger menstruation and the beginning of the next cycle. 
From the time of ovulation until progesterone withdrawal has caused menstruation to 
begin, the process typically takes about two weeks, with ten to sixteen days considered 
normal 6.
MENSES:
Absence of conception &cessation of glandular secretion
                                 Irregular breakdown of endometrium
                   Shedding of Decidua functionalis
                           Menses
The destruction of the corpus luteum and its production of estrogen and progesterone is 
the cause of the shedding 7.
ABNORMAL MENSES - TERMINOLOGY
RELATIONSHIP BETWEEN ENDOMETRIAL, ENDOCRINE AND OVARIAN 
CYCLE
 
THE THYROID GLAND
A  brief  description  of  Thyroid  physiology  and  its  effect  on  menstruation  is 
discussed here. The Thyroid (meaning “a shield”, because it shields the trachea) was 
first described by Wharton in the 19th century, weighs around 20 gms in the adult 8. The 
thyroid begins to function in the mid trimester of fetal life. 
 Microscopically, the gland contains 3 million follicles containing colloid which is 
made up of thyroglobulin.
CHEMISTRY
The Thyroid  gland secretes  three  hormones,  Thyroxine (T4),  Triiodothyronine 
(T3) and Calcitonin. In normal adult about one third of T4 secreted per day is converted 
into T3 in the liver and kidney. About 80% of T3 generated outside the gland.T3 is 3-5 
times more potent than T4.T3 is responsible for most of the thyroid action 9.
RECEPTORS
The nuclear  receptors  for  thyroid hormones  are  of  two types  α and  β.  These 
receptors  are  ubiquitous  and  this  explains  its  wider  action  in  the  body.T3  is  more 
effective because of greater affinity (10 fold) for thyroid receptors.
THYROID GLAND
ACTION OF THYROID HORMONES ON REPRODUCTIVE SYSTEM
Thyroid  hormones  have  pronounced  effects  on  the  growth  and  development, 
metabolism and on every body system.
The following facts explain the role of thyroid on reproductive physiology
 TSH receptors are found on granulosa cells.
 T3 and T4 have been found in follicular fluids
 T4  has  been  found  to  enhance  the  action  of  gonadotrophins  in 
luteinisation and progesterone secretion.
The female hormonal milieu and its potential effects on immune surveillance play 
a  role  in  the  increased  risk  of  women to  develop autoimmune  thyroid  disease.  The 
immunoglobulins  produced  against  the  thyroid  are  polygonal  and  the  multiple 
combinations of various antibodies present combine to create the clinical spectrum of 
autoimmune thyroid diseases that affect successful reproductive function 10.
HYPOTHYROIDISM
 Hypothyroidism  is  one  of  the  most  common  disorders  encountered  in 
endocrinological  office  practice.  Thyroid  disorders  are  10  times  more  common  in 
women than men (Morgante et al 1999) 11.
The  prevalence  of  overt  hypothyroidism varies  among  different  surveys  from 
0.1% to 2%. Subclinical hypothyroidism is much more prevalent and can be seen in as 
many as 15% of older women 12.
It  results from reduced thyroid hormone actions at  the peripheral  tissues.  This 
reduction in thyroid hormone action is in the vast majority of cases secondary to reduced 
thyroid hormone synthesis and secretion by the thyroid gland. Occasionally, peripheral 
resistance to thyroid hormone is the culprit.
Potential causes for hypothyroidism
 Primary
• Congenital absence of the thyroid gland
• External thyroid gland radiation
• Familial disorders of thyroxine synthesis
• Hashimotto thyroiditis
• Iodine-131 ablation for Grave’s disease
• Ingestion of Antithyroid drugs
• Iodine deficiency
• Idiopathic myxoedema
• Surgical removal of Thyroid gland
 Secondary
• Hypothalamic TRH deficiency
• Pituitary or Hypothalamic tumours or disease.
Primary hypothyroidism 
Primary hypothyroidism is responsible for the majority of hypothyroid cases. The 
following  discussion  reviews  the  most  common  entities  that  result  in  primary 
hypothyroidism.        
 Chronic  autoimmune  thyroiditis  is  the  leading  cause  of  primary 
hypothyroidism  in  iodine  deficient  areas  13.  Clinically  patients  with 
Hashimotto’s  thyroiditis  may  present  with  or  without  goitre. 
Pathophysiologically,  there  is  cell  mediated  and  antibody  mediated 
destruction of the Thyroid gland.
 Iodine  deficiency  causes  Hypothyroidism.  Patients  often  have  large 
goitres.
 Post ablative hypothyroidism develops several weeks after radioactive 
iodine therapy.
Secondary hypothyroidism
In secondary hypothyroidism the defect is in the pituitary or in the hypothalamus. 
From a practical point of view, the end result is the same: a reduction in biologically 
active  TSH.  In clinical  practice,  pituitary  adenomas  are  the  most  common cause  of 
central  hypothyroidism.  Depending  on  the  damage  incurred  by  the  hypothalamus-
pituitary axis, central hypothyroidism may be reversible or permanent. 
EFFECT OF HYPOTHYROIDISM IN ADULT WOMEN
Severe  hypothyroidism  is  associated  with  diminished  libido,  oligomenorrhea, 
amenorrhea, or anovulation. Secretion of progesterone is inadequate and endometrial 
proliferation  persists  resulting  in  excessive  and  irregular  breakthrough  bleeding. 
Hypothyroidism  appears  to  be  associated  with  decreased  fertility  resulting  from 
ovulatory difficulties and spontaneous abortions may result.
The values of plasma gonadotrophins are usually in the normal range in primary 
hypothyroidism.  In postmenopausal women, the levels are usually lower than euthyroid 
women of the same age but are nevertheless within the menopausal range. This provides 
a  valuable  means  of  differentiating  primary  from  secondary  hypothyroidism. 
Myxedematous infiltration can produce enlarged, cystic ovaries.
METABOLISM OF OESTROGENS IN HYPOTHYROIDISM
The metabolism of estrogens is  altered with respect  to oestradiol  and estrone, 
hypothyroidism favours the metabolism of steroids via 16 alpha hydroxylation over that 
via 2- oxygenation with the result the formation of oestriol is increased and that of 2- 
hydroxyestrone  and  its  derivative  2-methoxyestrone  is  decreased.  The  sex  hormone 
binding  globulin  concentrations  in  plasma  is  decreased  with  the  result  the  plasma 
concentrations  of  both  testosterone  and  oestradiol  are  decreased,  but  the  unbound 
fractions are increased. Fortunately, the alterations in steroid metabolism are corrected 
by restoration of the euthyroid state 5.
HYPERPROLACTINEMIA IN HYPOTHYROIDISM 
Patients with primary hypothyroidism may have mild to moderate serum prolactin 
elevation due to increased prolactin secretion under the stimulatory effect of TRH.   A 
decrease in T3 feedback in hypothyroidism may induce an increase in the hypothalamic 
TRH production.  Hyperprolactinemia  can  result  in  hypogonadotropic  hypogonadism. 
Hence there is reduced fertility and increased risk of miscarriage 14.   
The duration of hypothyroidism is important  with regard to the mechanism of 
amenorrhea, the longer the duration the higher the incidence of amenorrhea and higher 
the prolactin levels. This may be associated with decreasing hypothalamic content of 
dopamine  with  ongoing  hypothyroidism.  This  would  lead  to  an  unopposed  TRH 
stimulatory effect on the pituitary cells that secrete prolactin.
SUBCLINICAL HYPOTHYROIDISM
Subclinical hypothyroidism is the term used to define a state in which serum T3 
and T4 levels are within normal limits, but there is underlying mild thyroid failure, as 
evidenced by a mild increase in serum TSH 15. The condition is sometimes designated as 
compensated,  early,  latent,  mild,  minimally  symptomatic  and  preclinical 
hypothyroidism.
The  aetiology  of  subclinical  hypothyroidism  is  similar  to  that  of  overt 
hypothyroidism. Chronic autoimmune thyroiditis is the leading cause. Other common 
causes of subclinical hypothyroidism include thyroid ablation with radioactive iodine, 
partial  thyroidectomy,  antithyroid  drugs,  external  beam  irradiation,  drugs  such  as 
amiodarone, lithium or radiographic contrast agents and inadequate T4 therapy for overt 
hypothyroidism.
Subclinical hypothyroidism represents the early stage of the disease, and it has 
been shown that there is progression to overt hypothyroidism in approximately 4% to 
18% of patients who have subclinical hypothyroidism every year  16. The likelihood of 
progression to overt hypothyroidism increases in the presence of antithyroid antibodies, 
serum TSH values  greater  than 10µU/mL  ,  positive  history of  radioiodine ablation 
therapy, history of external radiation therapy for nonthyroid malignancies, and chronic 
lithium  treatment.  At  this  time there  is  evidence  that  subclinical  hypothyroidism is 
associated with hypertension, cardiac dysfunction and dyslipidemias. But importantly, 
women with subclinical hypothyroidism present with menstrual irregularities such as 
menorrhagia or fertility problems.
LABORATORY EVALUATION
The diagnosis of hypothyroidism is based in the combination of clinical context 
and laboratory tests. 
A number of factors affect the levels of TSH, total T4 and total T3. But the serum 
levels of free T4 remain normal in these circumstances and provide a better assessment 
of thyroid function. Patients who have primary hypothyroidism have elevated TSH and 
low FT4 and FT3. TPO antibodies are found in many patients who have hashimotto’s 
thyroiditis.
A repeatedly elevated TSH, between 4 and 15 mIU/mL, with normal FT4 and FT3 is 
suggestive of subclinical hypothyroidism 17. 
FREET3 FREET4 TSH DIAGNOSIS
normal normal normal Euthyroid status
elevated elevated low Hyperthyroidism
Low Low elevate
d
Hypothyroidism
normal normal elevate
d
Subclinical hypothyroidism
normal normal low Subclinical hyperthyroidism
                                     REVIEW OF LITERATURE
In women with menstrual irregularities, Thyroid dysfunction has a major share in 
the aetiology. On the contrary, menstrual disturbances may be the first  indication of 
underlying thyroid disorder.
• As  early  as  in  1927,  Gardner  and  Hill,  showed  an  association  between 
hypothyroidism and menorrhagia 18.
• Goldsmith et al in 1952 found that 8 out of 10 patients with hypothyroidism had 
ovulatory failure and only 2 had normal ovulation and menses 19.
• Rogers et al in 1958 found that ,change in character of uterine bleeding and length 
of the cycle were the most common problems observed in hypothyroid women 20.
• Blum  and  Blum  in  1972  studied  the  relationship  between  subclinical 
hypothyroidism and menorrhagia 21.
• Akande in 1975 stated that changes in FSH/LH ratios in hypothyroidism caused 
anovulatory cycles 22.
• Yuen B, keye, Knopff in 1976 demonstrated hyperprolactinemia causing luteal 
phase defect is associated with less severe forms of hypothyroidism 23.
• Andrew weeks et al in 1987 stated after analysing 650 women with menstrual 
irregularities  that  hypothyroidism  is  a  greatly  under  diagnosed  etiology  for 
menorrhagia 24.
• Robuschi  et  al  in  1987  have  concluded  in  their  study  that  hypothyroidism 
increases with age and is more common in older women. Up to 45% of thyroid 
tissue from women over 60 showed evidence of thyroiditis. The incidence of anti-
thyroglobulin antibodies is 7.4% of women over age 75 while 16.9% of women 
aged 60 and 17.4% of women over age 75 had elevated TSH levels. In women 
admitted in Geriatric wards 2-4% had hypothyroidism 25.
• Klee et al 1987, are of opinion that TSH based testing strategies minimise the 
problem of  abnormal  T4  study  and  significantly  reduce  the  number  of  TRH 
stimulation tests performed 26.
• Smith  et  al  in  1987  found  an  association  between  hypothyroidism  and 
menorrhagia with development of an advanced form of Von willebrand’s disease 
in  untreated hypothyroidism.  The haemostatic  defects  returned to  normal  with 
thyroxine replacement 27.
• Hingham in 1992 reported a case of hypothyroidism in which the menstrual loss 
was measured. An initial loss of 480 ml decreased to 58 ml following 3 months of 
treatment with thyroxine 28.
• Wilansky DL, Griesman B in 1992 performed Thyrotrophin releasing hormone 
(TRH) test in 67 women who complained of excessive menstrual loss. All had 
normal levels of thyroxine and thyrotrophin. They found that 22% had abnormal 
TRH tests and they treated these women with thyroxine. At follow up between 12 
and 36 months later all considered their menstrual loss to be normal. In the 16 
women with normal TRH tests, 56% still complained of menorrhagia 29.
• Blum and Blum in 1992 studied the possible relationship between menorrhagia 
and occult hypothyroidism in IUD wearing women. They studied 40 women with 
menorrhagia secondary to an intrauterine contraceptive device.  They all  had a 
normal free thyroxine and TSH levels. The 10 patients who had the highest TSH 
levels were given a TRH test and all proved to have early hypothyroidism. All 
patients reported a significant improvement with thyroxin treatment30. 
• Joshi JV et al, 1993 in their study on 178 women referred to thyroid clinic found 
that,  reproductive  failure  (infertility,  pregnancy  wastage,  lactation  failure) 
occurred in 37.5% of hypothyroid women against 16.3% of euthyroid and 16.7 % 
of  healthy  controls.  Interestingly,  in  45% of  cases  menstrual  abnormality  was 
antecedent to other clinical features by a variable period of two months to ten 
years.  Reproductive  dysfunction  and  lactation  failure  also  preceded  thyroid 
dysfunction or goitre 31. 
• Danase MD et al in 1996 had stated that Hypothyroidism was frequent enough to 
warrant consideration in most elder women. They recommended screening with 
highly  sensitive  TSH assay  every  two  years  beginning at  age  60  or  with  the 
appearance of any symptom suggesting hypothyroidism 4.
• Chameron  &  Fraser  in  1998  in  their  article  on  the  clinical  disorders  of  the 
endometrium and the menstrual  cycle had stated that thyroid disorders are the 
most  common  endocrine  abnormality  associated  with  menstrual  disturbances. 
Hypothyroidism is a potent cause of menorrhagia amenable to treatment 32.
• Shaw  RW  in  1999  conducted  a  study  to  analyse  the  effect  of  thyroxine 
replacement on menstrual blood loss in hypothyroid patients. There was a relative 
improvement in haemoglobin concentration and general condition of the patients 
33.
• Prentice et al – Medical management of menorrhagia – 1999 have stated that all 
women with unexplained menorrhagia should be tested for hypothyroidism 34.
• Krassas  GE  et  al  1999-  Disturbances  of  menstruation  in  hypothyroidism had 
stated that oligo-amenorrhea or hypermenorrhea-menorrhagia can be present in 
women having thyroid failure 35. 
SUBCLINICAL HYPOTHYROIDISM
Huber G, Mitrache C, Gugliemetti M et al. Predictors of overt hypothyroidism 
and natural course 36: a long –term follow up study in impending thyroid failure-1998 . 
In this follow up study of 450 patients of subclinical thyroid disease they found that the 
progression to overt hypothyroidism is approximately 4% to 18% every year. On further 
analysis they formulated the predictors which in a given patient increases the likelihood 
of progression to overt hypothyroidism .The predictors are
  TSH Levels >10 mIU/L
  symptoms and signs of thyroid failure
  convincing family history of thyroid disease
 Pregnant patients
 Strong habit of tobacco use
 Severe hyperlipidemia
Surks MI, Ortiz E, Daniels GH, et al .2004, did a scientific review for formulating 
guidelines  in  management  of  subclinical  thyroid  disease  .They  concluded  that 
subclinical thyroid disease is associated with significant clinical impairment in affected 
patients and if so treatment with levothyroxine gives better outcomes. The consensus 
was that there was good evidence that treatment of patients who have TSH levels above 
4.5  mU/L  prevents  progression  to  overt  hypothyroidism.  And  the  evidence  was 
convincing that early treatment was beneficial 37. 
Surks MI. 2005, proposed a joint statement on the screening of subclinical thyroid 
disease. Thyroid screening is recommended in high risk women, such as those who have 
a personal history of thyroid or other autoimmune disorders, or those who have a family 
history of thyroid disorders, or presenting with symptoms of thyroid failure 38. 
Universal  screening  of  women  for  subclinical  hypothyroidism  and 
hypothyroxinemia  is  not  recommended  because  there  is  no  evidence  to  justify  the 
efficacy of screening and treatment and there have been no interventional studies to 
prove that this improves outcome.
Wilson  GR,  Curry  RW  Jr.subclinical  thyroid  disease.2005.  They  defined 
subclinical thyroid disease as a state in which serum T4 and T3 are within normal limits 
but there is mild increase in TSH. They are of opinion that patients with subclinical 
disease may be asymptomatic or may present with vague, non specific symptoms like 
fatigue,  generalised  weakness,  depression  and  memory,  cognitive  and  sleep 
disturbances. As in other thyroid disease, there is female preponderance. Women with 
sub  clinical  thyroid  disease  may  present  with  menstrual  irregularities  such  as 
menorrhagia or fertility problems 39.  
Wartofsky L et al - overt and subclinical hypothyroidism in women 40-2006. They 
stated that mild thyroid failure represents early stage of the thyroid disease. Chronic 
autoimmune thyroiditis is the leading cause. Few other causes include 
 Thyroid ablation with radioiodine
 Partial thyroidectomy
 Antithyroid drugs
 External beam radiation
 Drugs such as amiodarone and lithium
 Radiographic contrast agents.
Because of the increasing trend of autoimmune diseases, drug intake and radiation 
exposure the prevalence of thyroid diseases is on the rise.
Jorde Rolf et  al,  2006 in a study on effect of treatment on subclinical thyroid 
disease reported that thyroxine replacement should become the standard care for patients 
who have  subclinical  thyroid disease.  Future  studies  should shed more  light  on this 
subject.  
AIM AND OBJECTIVES
This study aimed at analysing the cross sectional population,
 To determine the association between menstrual irregularities and 
thyroid function
 To analyse  the  pattern  of  menstrual  dysfunction  among women 
with thyroid disorder
 To estimate the prevalence of subclinical thyroid disease among 
reproductive age group women with abnormal uterine bleeding
 To analyse the possible predictors which in a given patient helps in 
early testing of thyroid function to diagnose them in the subclinical 
stage.
MATERIALS AND METHODS
STUDY DESIGN: Analytical study 
STUDY PERIOD
August 2008 to September 2009
SAMPLE POPULATION: 
The  study  population  consisted  of  250  women  attending  the  gynaecology 
outpatient clinic, Institute of social obstetrics & Govt.kasturba Gandhi hospital, with the 
following complaints in the age group of 18 to45 years,  
1. Oligomenorrhea – where the cycle length lasts longer than 35 days
2. Hypomenorrhea – lesser bleeding which lasts for 2 days or less.
3. Menorrhagia-  cyclical  bleeding  at  normal  intervals  which  is  excessive  in 
amount(>60 ml/ changes 6 pads per day/associated with clots)
4. Polymenorrhea-  cyclical  bleeding  which  is  normal  in  amount,  but  occurs  in 
intervals of <21 days.
5. Amenorrhea – absence of menstruation
The patients were selected on the basis of Inclusion and Exclusion criteria as follows: 
Inclusion criteria:
  age group 18 to 45 years
 with any of menstrual disturbances described above
 no demonstrable pelvic pathology
 not an IUCD user
 not on thyroxine replacement therapy
 with symptoms of  thyroid dysfunction.
Symptoms of hyperthyroidism 
 Weight loss ( >10 kg in 3 months or subjective weight loss)
 Diarrhoea
 Heat intolerance
 Tremors
 Eye changes
 Palpitations
Symptoms of hypothyroidism
  Change of voice
 Weight gain
 Constipation
 Dryness of skin
 Cold intolerance
 Fatigue/lethargy
 Sleep disturbances
Exclusion criteria
 Women not in age group <18 and >45.
 Presence of palpable pelvic pathology
 With overt hypothyroidism on thyroxine. 
 known thyroid disorders
 On drugs  like  aspirin,  heparin,  antithyroid  agents,  steroids, 
amiodarone and lithium
          
 After proper selection of patients a detailed menstrual history elicited and other 
details as per proforma enclosed.
A  thorough  history  as  to  the  presence  of  symptoms  of  hypothyroidism  or 
hyperthyroidism was taken.
• Evaluation of general condition of patient(height, weight, BMI, anaemia, goitre, 
galactorrhoea)
• The cardiovascular, respiratory and nervous systems were evaluated
• Gentle abdominal, speculum and internal examination done
• 5 ml of venous blood was taken in a plain glass tube without any anticoagulant: 
morning sample in a fasting state taken and serum was separated to estimate free 
T3, T4 & TSH.
• FreeT3 & Free T4 assay was done using competitive EIA and TSH   by sandwich 
enzyme linked immunosorbent assay using kit supplied by Lilac Medicare pvt. 
Limited, Mumbai.
• THYROID –REFERENCE RANGE
HORMONE REFERENCE RANGE
TSH 0.5 – 5.0 mIU/L
FREE T3 1.7 – 4.2 pg/ml
FREET4 0.30 – 5.5 µIU/Ml
• BMI was calculated by the formula
                         Body mass index = weight in kg/ height in m2.
Standards 
BMI Inference
<18  Lean
18 - 24 Normal
25 -29 Overweight
30 -34 Obese
>35 Morbid obesity
                              
RESULTS & ANALYSIS
TABLE 1
AGE DISTRIBUTION IN STUDY GROUP
AGE GROUP FREQUENCY PERCENTAGE
18-24 years 36 14.4%
25-31 years 103 41.2%
32-39 years 81 32.4%
>40 years 30 12.0%
Among the 250 women under study majority were in the age group 25-31years(41.2%).  

TABLE 2
Distribution of cases according to PARITY 
   PARITY FREQUENCY PERCENTAGE
NULLIPARA 27 10.8%
P1L1 62 24.2%
P2L2 98 39%
MULTIPARA 63 25%
Majority of patients were P2L2.
TABLE - 3
REPRODUCTIVE DYSFUNCTION IN STUDY GROUP
REPRODUCTIVE 
DYSFUNCTION
NUMBER  PERCENTAGE
Nil 214 85.6%
Infertility 14 5.6%
Pregnancy wastage 22 8.8%
Among 250 women in reproductive age group with AUB presented to general gynaec 
clinic, 5.6% had infertility and 8.8% had history of abortions
Table - 4
TYPE OF AUB
TYPE OF AUB FREQUENCY PERCENTAGE
Amenorrhea 25 10%
Menorrhagia 148 59.2%
Oligomenorrhea 68 27.2%
Hypomenorrhea 4 1.6%
Polymenorrhea 5 2%
FREQUENCY
Amenorhea
Menorrhagia
Oligomenorrhea
Hypomenorrhea
Polymenorrhea
Majority in study group had menorrhagia (59.2%) and oligomenorrhea (27.2%).
TABLE - 5
DURATION OF AUB
AUB DURATION FREQUENCY PERCENTAGE
1-3 months 48 19%
4-6 months 125 50%
7 months- 1 yr 41 16%
1-2 years 24 9.6%
>2 years 5 2.0%
Since menarche 7 2.4%
Many patients in the sample presented with AUB of 4-6 months duration.
TABLE – 6
SYMPTOMS OF THYROID DYSFUNCTION
SYMPTOMS NUMBE
R
PERCENTA
GE
Asymptomatic 181 72.4%
Weight gain 20 8%
Cold intolerance 7 2.8%
Lethargy 7 2.8%
Constipation 3 1.2%
Hoarseness of voice 2 0.8%
Weight loss 13 5.2%
Anxiety 7 2.8%
Heat intolerance 5 2%
Palpitations 2 0.8%
Tremors 2 0.8%
Diarrhoea 1 0.4%
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Symptoms of thyroid dysfunction
72.4% of patients had no symptoms of thyroid dysfunction. Weight gain (8%) was 
the most frequent symptom.
SIGNS OF THYROID DYSFUNCTION
SIGNS NUMBER PERCENTAGE
Slow movements 13 5.2%
Coarse skin 15 6%
Cold skin 14 5.6%
Periorbital puffiness 6 2.4%
Delayed ankle jerk 2 0.8%
Myxoedema 2 0.8%
Bradycardia 5 2.0%
Signs of Thyroid dysfunction
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TABLE -7
GENERAL EXAMINATION
General examination Number Percentage
Normal 191 76.4%
Anaemia 59 23.6%
Goitre 0
23.6% of patients had clinical anaemia and the rest were normal.
TABLE - 8
BMI- BODY MASS INDEX
BMI RANGE NUMBER PERCENTAGE
<18(lean) 3 1.2%
18-24(normal) 202 80.8%
25-29(overweight) 24 9.6%
30-34(obese) 16 6.4%
>34(morbid obesity) 5 2.0%
TABLE - 9
GYNAECOLOGICAL EXAMINATION
CLINICAL 
UTERINE SIZE
NUMBER PERCENTAGE
Normal 242 96.8%
Bulky uterus 8 3.2%
TABLE - 10
HAEMOGLOBIN ESTIMATION
Haemoglobin in gms% number Percentage
<11gms 59 24%
>11gms 191 76.4%
TABLE – 11
DILATATION & CURETTAGE
ENDOMETRIAL 
HISTOLOGY
NUMBER PERCENTAGE
Secretory 55 22%
Proliferative 177 70.8%
Hyperplasia 18 7.2%
TABLE - 12
ULTRASONOGRAM
USG findings Number Percentage
Normal 201 80.2%
Bulky uterus 12 4.8%
Cystic ovaries 37 15%
TABLE – 13
T3 VALUES (1.7-4.2 pg/ml)
T3 (pg/ml) NUMBER PERCENTAGE
< 1.7 39 15.6%
1.7-4.2 193 77.2%
>4.2 18 7.2%
TABLE - 14
T4 VALUES (0.70-1.80 ng/ml)
T4(ng/ml) NUMBER PERCENTAGE
<0.70 39 15.6%
0.70-1.80 193 77.2%
>1.80 18 7.2%
TABLE - 15
TSH VALUES (0.5-5.0 mIU/ml)
TSH NUMBER PERCENTAGE
<5.0 18 7.2%
0.5-5.0 173 69.2%
>5.0 59 23.6%
TABLE - 16
TYPE OF THYROID DYSFUNCTION
TYPE OF THYROID 
DYSFUNCTION
NUMBER PERCENTAGE
HYPOTHYROIDISM 39 15.6%
NORMAL 173 69.2%
HYPERTHYROIDISM 18 7.2%
SUBCLINICAL 
HYPOTHYROIDISM
20 8.0%
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TABLE - 17
RELATION OF AGE WITH THYROID DYSFUNCTION
Cross table
According to the above data, there is significant association (p<0.001) 
between  age 
and thyroid dysfunction. With increasing age, thyroid dysfunction increases
AGE & THYROID DYSFUNCTION
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.TABLE - 18
TYPE OF AUB AND THYROID DYSFUNCTION
TYPE OF AUB AND THYROID DYSFUNCTION
0%
20%
40%
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80%
100%
normal Hypothyroidism hyperthyroidism subclinical
hypothyroidism
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Table - 19
MENSTRUAL DYSFUNCTION IN HYPOTHYROIDISM
Menstrual dysfunction No. of hypothyroids Percentage
Oligomenorrhea 3 12.8%%
Menorrhagia 29 61.6%
Amenorrhea 7 25.6%
Hypomenorrhea 0 0
polymenorrhea 0 0
Among 39 women with hypothyroidism, 29(61.6%) had menorrhagia and7(25.6%) had 
amenorrhea.
Table - 20
MENSTRUAL DYSFUNCTION IN HYPERTHYROIDISM
Menstrual No. of hyperthyroids Percentage
dysfunction
Oligomenorrhea 17 94.5%
Menorrhagia 1 5.5%
Amenorrhea 0 0
Hypo & 
polymenorrhea
0 0
Oligomenorrhea (94.5%) was more frequent in hyperthyroid women.
Table - 21
MENSTRUAL DYSFUNCTION IN SUBCLINICAL HYPOTHYROIDISM
Menstrual dysfunction Subclinical 
hypothyroidism
Percentage
Oligomenorrhea 2 5%
Menorrhagia 14 70%
Amenorrhea 4 25%
Hypo & polymenorrhea 0 0
Among 20 women detected to have early hypothyroidism, 14(75%) had menorrhagia, 
4(25%) had amenorrhea and 2(5%) had oligomenorrhea.
According  to  the  above  available  data,  there  is  a  significant  correlation  (p<0.001) 
between type of menstrual dysfunction and thyroid dysfunction.
Table – 22
DURATION Vs THYROID DYSFUNCTION
AUB DURATION NORMAL THYROID 
DYSFUNCTION
TOTAL
1-3 months 
% of total
38 
15.2%
10 
4%
48 
19.2%
4-6 months 
% of total
95 
38%
30 
12%
125 
50%
7mon –1 yr 
% of total
20 
8.0%
21 
8.4%
41 
16.4%
1-2 yrs 
% of total
13 
5.2%
11 
4.4%
24 
9.6%
>2 years 
% of total
2 
0.8%
3 
1.2%
5 
2%
Since menarche 
% of total
5 
2%
2 
0.8%
7 
2.8%
TOTAL
% of total
173
69.2%
77
30.8%
250
100%
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According to the above data,  there  is  significant  correlation (p<0.05)  between 
duration of menstrual symptoms and presence of thyroid dysfunction.
Table - 23
BMI AND HYPOTHYROIDISM
BMI HYPOTHYROID 
WOMEN-NUMBER
PERCENTAGE
<18(underweight) 0 0
18-24(normal) 11 28.3%
25-29(overweight) 13 33.4%
30-34(obese) 12 30.7%
>34(morbid obesity) 3 7.6%
Women with abnormal BMI showed more occurrence of hypothyroidism.
Table – 24
BMI & HYPERTHYROIDISM
BMI HYPERTHYROID-
NUMBER
PERENTAGE
<18 1 33.3%
18-24 14 69.3%
25-30 3 12.5%
31-34 0 0
>34 0 0
TABLE - 25
BMI AND THYROID DYSFUNCTION
BMI Normal Presence  of 
Thyroid 
dysfunction
Total
<18            count 
% of total
2 
0.8%
1                   0.4% 3     1.2%
18-24         count 
% of total
158 
63.2%
44                  17.6% 202 
80.8%
25-29         count 
% of total
8 
3.2%
16                 6.4% 24 
9.6%
30-34          count 
%of total
3 
1.2%
13                  5.2% 16   6.4%
>34            count 
% of total
2 
0.8%
3                  1.2% 5     2.0%
Total 173 
69.2%
77 
30.8%
250 
100%
According to the above data, women with abnormal BMI had abnormalities in thyroid 
function.
BMI & THYROID DYSFUNCTION
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Table -26
REPRODUCTIVE DYSFUNCTION AND THYROID DISORDERS
 REPRODUCTIVE 
DYSFUNCTION
 NO  THYROID 
DYSFUNCTION
 THYROID 
DISORDERS
TOTAL
NIL 
% of total
156 
62.4%
58 
23.2%
214 
85.6%
INFERTILITY 
% of total
8 
3.2%
6 
2.4%
14 
5.6%
PREGNANCY WASTAGE 
% of total
9 
3.6%
13 
5.2%
22 
8.8%
TOTAL 173 
69.2%
77 
30.8%
250 
100%
Reproductive failure &Thyroid dysfunction
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From the above data it  is  derived that  there is  significant  correlation (p<0.05) 
between reproductive dysfunction and presence of thyroid disorders.
DISSCUSION
Abnormal  uterine  bleeding  is  a  benign  yet  debilitating  disease  with  a  strong 
association with thyroid disorders. This study highlights the association between AUB 
and Thyroid dysfunction by measurement of free T3, free T4, and TSH.
• In our study, the mean age of women with thyroid dysfunction was 36years. C A 
Petta et  al  2007 in their  cross sectional  study carried out  in 148 women with 
menstrual dysfunction found a mean age of 34.6 years 41.
           Vanderpump MP et al 1995, in their 20 years follow up of whickam survey had a 
mean age of 34 years for occurrence of thyroid disorders. They also stated development 
of  hypothyroidism  increases  with  age  but  no  age  relation  for  hyperthyroidism  42. 
Sampath S et al 2007, in their study on clinicobiochemical spectrum of hypothyroidism 
found a mean age of 36.2 years among 944 women referred for thyroid testing. Also, 
they found that the mean age of females with subclinical hypothyroidism is 5.4 years 
less than those with overt hypothyroidism 43. 
• In this study we found an association in the occurrence of menorrhagia(59.2%) in 
hypothyroid  women  .In  a  retrospective  analysis  by  Andrew  D  Weeks  2000, 
among 50 patients with myxoedema, 28(56%) had menstrual disturbances and the 
most common complaint was menorrhagia(36%)  44. Col P Singh et al 2007, in 
their  analysis  of  menstrual  dysfunction  among  hypothyroid  women  stated, 
`menorrhagia was seen in 32.4% of hypothyroid women’ 45. 
• Also in the present study, oligomenorrhea (94.5%) was more frequent in women 
found to have hyperthyroidism. this association correlated with the findings in 
other studies. Tunbridge et al -2002, in their study on analysis of bleeding pattern 
in  hyperthyroid  subjects,  detected  Oligomenorrhea  to  be  more  frequent  in 
hyperthyroid subjects with the occurrence of 80% 46. In another study by Daniels 
-2004  had  a  85%  prevalence  of  Oligomenorrhea  in  hyperthyroid  patients  47. 
Hence, screening of thyroid function in these women with menstrual dysfunction 
is of great significance.
• In community  surveys,  it  has been detected that  women developing milder  or 
early  forms  of  hypothyroidism  may  have  menstrual  abnormalities  as  the 
presenting  feature48-50.  In  this  study,  women  diagnosed  of  subclinical 
hypothyroidism  presented  with  menorrhagia  (75%)  and  amenorrhea  (20%).on 
comparison with other studies, this association is significant. Wilson GR et al, in 
their article on subclinical  thyroid disease,  stated the menstrual  dysfunction in 
preclinical  hypothyroids will  be  similar  to  that  in  overt  hypothyroidism39.  The 
findings  of  the  present  study  correlated  with  the  76%  occurrence  of 
Oligomenorrhea  16% occurrence  of  amenorrhea  in  a  study  by  Jorde  et  al  on 
endocrinological disturbances in hypothyroid women51. 
• Another  association found in  the study was correlation of  thyroid dysfunction 
with  duration  of  menstrual  dysfunction.  Majority  patients  presented  with 
abnormal bleeding of > 4 months duration had increased occurrence of thyroid 
abnormalities(85%).This correlation is found in a similar study by Sampath et al 
on clinicobiochemical spectrum of thyroid disease 43, according to them, 65% of 
women had their onset of menstrual complaint before mean duration of 6 months.
• In the present study, among 39 women detected to have hypothyroid, 20 (51%) 
had weight gain as their complaint followed by fatigue in 7(28%) women. Out of 
18 patients with hyperthyroidism, weight loss (43%) and anxiety (23%) were the 
clinical  symptoms.  Complaints  of  almost  all  symptoms  related  with 
hypo/hyperthyroidism  were  statistically  more  frequent  among  women  with 
thyroid dysfunction. The symptoms of thyroid dysfunction were more predictive 
of the disease. This has been previously demonstrated in other studies.  Sampath S 
et al 2007, on their analysis on clinical presentation of hypothyroid cases 43found 
weight  gain  as  the  commonest  symptom  (53.8%)  followed  by  generalized 
weakness (36%). 
The most  specific  and discriminating feature  of  hypothyroidism are  decreased 
sweating, hoarseness of voice, paresthesias, cold intolerance (Utiger RD et al 1995)52. 
However in this study, we found symptom of weight gain (51%) was more common.
• In the present study, hyperthyroid subjects,  presented with symptom of weight 
loss  (56%)  and  anxiety  (39%).  This  frequency  was  similarly  stated  in  other 
studies.  Stoffer  SS  et  al,  clinical  features  of  patients  with  Grave’s  disease53, 
detected that loss of weight (74%) and anxiety (53%) symptoms are the prominent 
features. Vitti P et al, in their analysis on clinical presentation of graves disease 
found heat intolerance and tremors were common 54. But in our study, we found 
weight loss (56%) and anxiety (39%) to be common.
• BMI abnormality in the sample population of the present study correlated well 
with  thyroid  abnormalities.  Women  with  normal  BMI  had  less  occurrence  of 
thyroid dysfunction (19.3%) in contrast to those with high BMI who had 62.2% 
occurrence. This association is well proved in other studies. Tomlinson et al, in 
their  analytical  study  on clinical  and  endocrinological  characteristics  of  obese 
women  55cited  a  65%incidence  of  thyroid  dysfunction  among  women  with 
abnormal BMI. Similar incidence of 72% was concluded by Pi-Sunyer FX et al in 
their analysis on medical hazards of obesity 56.
• In  this study, the presence of infertility (2.4%) and h/o abortions (5.2%) were 
associated with significant thyroid abnormalities. Though significance is cited the 
prevalence  is  not  in  agreement  with  29%  prevalence  of  thyroid  dysfunction 
described by Poppe et al 2002 in their study on thyroid dysfunction in infertile 
women 57 and in another study by Sampath et al (2007), where 34.3% of infertile 
women  and  10.2% of  women  with  pregnancy  wastage  had  thyroid  failure  43. 
Because in the previous two studies, the sample population consisted of women 
with infertility and recurrent pregnancy loss. Whereas in the present study, the 
sample population was taken from the general gynaec clinic which would have 
accounted for the less prevalence.
In  an  analysis  on  prevalence  of  hypothyroidism  in  women  referred  for  gynaec 
complaints  by  Ram Chandra  rao  et  al-  2008,  quoted  a  prevalence  of  4.2%  among 
infertile  women58.  Vinita  et  al-2003,  conducted  a  cross  sectional  study  on 
endocrinological  factors  in  reproductive  dysfunction,  cited  a  prevalence  of  thyroid 
abnormalities in 2.44%  59 .In the present study ,thyroid abnormalities were prevalent 
among 2.4% of infertile women and in 5.2% of women with pregnancy wastage. 
• The overall prevalence of thyroid dysfunction in the present study was 30.8 %
(  selective  screening  of  this  population  has  resulted  in  a  higher  yield).  This 
correlates with other studies,
Prentice et  al-  medical  management of menorrhagia  34 – stated 36% of women with 
thyroid  abnormalities  had  menstrual  dysfunction.  In  another  study  by  Wilansky  et 
al-1999(early hypothyroidism in menorrhagia)  29, had 22% prevalence among patients 
with thyroid disorder.
• Our  findings  for  the  prevalence  of  subclinical  hypothyroidism are  within  the 
expected range for the female population of reproductive age. Prevalence studies 
have reported incidences between 4 – 10 %( Mark PG et al 1995) 60.
Hollowell JG et al 2002 observed 8.3% prevalence of subclinical hypothyroidism 
in  their  study  61.  It  was  observed  in  our  study  that  8% of  women  with  AUB  had 
subclinical  hypothyroidism.  This  should  be  considered  the  major  benefit  of  testing 
because progression rate to overt hypothyroidism is approximately 4% to 18 %( Huber 
G 1998). There are enough data to support the fact that thyroxine replacement in women 
with subclinical hypothyroidism checks progression. 
The prevalence of subclinical hypothyroidism in our study doesn’t correlate with 
the  14.6%  prevalence  in  study  by  Bemben  DA  1994(predictability  of  subclinical 
hypothyroidism in women) 62.  Because, in this study the sample population were in the 
age group 60-97 years. In community surveys 8-17% of people older than 55 years may 
have subclinical hypothyroidism (Parle JV et al 1991) 63.
There  is  good  evidence  to  support  the  fact  that  treatment  of  patients  with 
subclinical  hypothyroidism who have TSH levels  >5 mIU/L prevents  progression to 
overt hypothyroidism (Surks MI 2004). Failed medical therapy of DUB may be due to 
underestimate of underlying thyroid disorder. 
SUMMARY
The  study  was  undertaken  in  250  women  with  abnormal  uterine  bleeding  in 
reproductive age group presenting to our tertiary referral hospital. It was done to assess 
the prevalence and the possibility of a correlation between subclinical thyroid disease 
and AUB.
A  detailed  history  elicited  as  per  proforma  enclosed  and  anthropometric 
measurements  were  taken  and  a  thorough  general  and  systemic  examination  done. 
Thyroid function analysis was done in each of these women and the results interpreted.
The mean age of women in the study group was 36 years. There was significant 
correlation between increasing age and thyroid dysfunction. 
A significant correlation with reproductive failure and thyroid abnormalities was 
cited in the study. Nulliparous women presented earlier with infertility as their primary 
complaint  and statistical  significance was  also detected  in  women with reproductive 
dysfunction. 
Women  symptomatic  of  thyroid  abnormalities  had  more  incidence  of  thyroid 
dysfunction.  The  symptoms with  which  they  presented  were  more  predictive  of  the 
disease.  There was also significance between duration of symptoms and presence of 
thyroid  abnormalities.  BMI  was  significantly  abnormal  more  so  in  patients  with 
hypothyroidism and menorrhagia.
 In oligomenorrhic women, thyrotoxicosis was more common with incidence of 
94.5%  and  menorrhagia  was  observed  in  59.2%  of  hypothyroid  women.   Women 
detected to have subclinical hypothyroidism also presented with menorrhagia (70%) and 
amenorrhea (25%).Frequency of polymenorrhea and Hypomenorrhea in the study group 
was relatively low due to the increased incidence of pelvic pathology associated with 
polymenorrhea.  Among 4 women in the study group with Hypomenorrhea and 5 
with Polymenorrhea, none had thyroid abnormalities.
In  the  study  group,  the  overall  prevalence  of  thyroid  abnormalities  was 
30.8%.Among them 15.6% had hypothyroidism and 7.2% had hyperthyroidism and 8% 
had subclinical hypothyroidism. 
Prevalence:
Hypothyroidism – 15.6%
Hyperthyroidism –7.2%
Subclinical hypothyroidism –8%
The  prevalence  of  preclinical  hypothyroidism  was  8%.  These  women  had 
abnormal  bleeding  of  a  lesser  duration  (4-6months).  13  out  of  20  women  with 
subclinical hypothyroidism had symptoms attributable to thyroid dysfunction. Detection 
of  this  group  of  women  is  considered  a  major  benefit  of  testing  because, 
supplementation of thyroxine to this group of women will revert back their symptoms 
and checks progression of their endocrinological disease. All of them had their TSH 
values between 5 and 8 mIU/L. 
Women  detected  to  have  overt  hypo/hyperthyroidism  had  longer  duration  of 
symptoms and they are now actually detected at a farther end in the spectrum of disease 
after  acquiring morbidity  in the form of affliction of  their  quality of  life  due to the 
abnormal bleeding and by the onset of anaemia. Hence testing for thyroid function is 
advocated early in the course of the disease. 
                                     
CONCLUSION
 Our study highlights the following,
• There is significant association between thyroid disorders and abnormal uterine 
bleeding. 
• It  brings into focus the increased incidence of hypothyroidism among women 
with menorrhagia and amenorrhea.  And increased incidence of hyperthyroidism 
in women with oligomenorrhea. 
• The prevalence of subclinical hypothyroidism in the study group was 8%. 
• It  is  suggested that  women with early  onset  menorrhagia  and oligomenorrhea 
with or without symptoms & signs attributable to thyroid dysfunction should be 
offered thyroid function testing to detect them in the subclinical stage. 
• Early  detection  by  selective  screening  and  specific  pharmacotherapy  for 
subclinical thyroid disease early in the course of the disease will prove to be a 
superior alternative to surgical treatments like hysterectomy.
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ABBREVIATIONS
AUB  - Abnormal Uterine Bleeding
T4- Thyroxine
T3-Tri-iodothyronine
TSH- Thyroid Stimulating Hormone.
TRH-Thyrotropin releasing hormone
LH- Leuteinising Hormone.
FSH-Follicle Stimulating Hormone.
hCG-Human Chorionic Gonadotropin.
SHBG-Sex Hormone Binding Globulin.
FT3-Free tri-iodothyronine
FT4-Free thyroxine.
TPO- Thyroid peroxidase
BMI-Body Mass Index
IUCD- Intra Uterine Contraceptive Device
PID- Pelvic Inflammatory Disease.
EIA-Enzyme Immuno Assay
SC Hypo-Subclinical hypothyroidism.
PROFORMA
 PREVALENCE  OF  SUBCLINICAL  HYPOTHYROIDISM   IN 
REPRODUCTIVE  AGE  GROUP  WOMEN  WITH  ABNORMAL  UTERINE 
BLEDING
SERIAL  NO: 
HOSPITAL NO. :
NAME :                                                                               OCCUPATION :
AGE:
ADDRESS:
SOCIO- ECONOMIC STATUS:
1. CHIEF COMPLAINTS:
2. HISTORY OF PRESENTING COMPLAINTS:
A) Bleeding per Vagina:
Duration:
Interval:
Quantity: Scanty / Moderate /Excessive
H/o Dysmenorrhoea: Yes /No
- CLINICAL EVALUATION OF THYROID DISORDER
Change of Voice   :     Yes / No
Weight Gain          :     Yes /No  
Constipation          :     Yes / No
Dryness of Skin     :     Yes / No 
Cold Intolerance    :     Yes / No
Fatigue/Lethargy    :     Yes / No
Sleep Disturbance   :    Yes / No
Other Details if any: 
3. MENSTRUAL HISTORY:
Acyclical: Yes /No
Hypomenorrhoea: Yes /No
Menorrhagia: Yes /No
Metrorrhagia: Yes /No
Oligomenorrhea: Yes /No
Polymenorrhea: Yes /No
Age of attainment of menarche:
Previous Menstrual cycles-
• Duration of Cycles:
• Amount of flow:
• Duration of flow:
• Associated Dysmenorrhoea:
Date of last menstrual period:
4. OBSTETRIC HISTORY:
Married Life:     Parity:      
Abortion:            Last child birth:
Type of Deliveries:                        Tubectomy: Yes / No
5. PAST HISTORY:
HT/DM/TB / Bronchial asthma/ Radiation/Blood transfusion / Any thyroid surgeries
6. FAMILY HISTORY:
TB / Bronchial Asthma / Diabetes mellitus / Hypertension / Any cancer/thyroid illness.
7. PERSONAL HISTORY:
Diet:      Appetite:          Bowels:
Micturition:           Sleep:
EXAMINATION OF PATIENT:
1) General Condition              2) Nutritional Status
3) Anemia                            4)BMI      5) CVS/RS/CNS
6) vital signs
7) Breast and Thyroid
8. PER ABDOMEN:
Operative scar: Present / Absent
Engorged vein: Present / Absent
Ascites: Present / Absent
Any enlargement of Liver / Spleen: Palpable / Non Palpable
9. EXTERNAL GENITALIA: Healthy / Non Healthy
10. PER SPECULUM EXAMINATION:
Vagina:
Cervix:
Bleeding: Present / Absent
11. PER VAGINAL EXAMINATION:
Cervix: Normal / Flush with vault
Uterus: Anteverted / Retroverted
Normal size / Bulky/ smaller
Soft / Firm / Hard
Mobile / Fixed
Tender / Non Tender
Tenderness in fornix: Present / Absent
12. Per rectal Examination:
 13. INVESTIGATIONS:
• Urine: Albumin/ Sugar/ Microscopy
• BT CT
• Complete hemogram
• Blood sugar,urea,creatinine
• Blood grouping & typing
• Pelvic USG
• Histopathology of Endometrium 
Thyroid Function Test
       -Free T3  - Free T4
      -TSH
